Clinical Trial Update: S0521, Combination Chemotherapy With or Without Gemtuzumab Followed By Tretinoin, Mercaptopurine, and Methotrexate or Observation in Treating Patients With Acute Promyelocytic Leukemia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating combination chemotherapy with or without gemtuzumab followed by tretinoin, mercaptopurine, and methotrexate or observation in acute pro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Promyelocytic Leukemia

Drugs mentioned

• Gemtuzumab (gemtuzumab ozogamicin)
• METHOTREXATE (METHOTREXATE)
• Mercaptopurine (Mercaptopurine)
• TRETINOIN (TRETINOIN)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Leukemia | Phase 3 | Status: COMPLETED | Results posted: 2014-07-18